TOBAM – Neurocrine Biosciences, Inc. Transaction History
TOBAM portfolio value:
$30.46M
portfolio value
TOBAM quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.40% | -19.62K shares | 592K | $106.21 | 286.87K |
| Q2 2022 | share | Increase | +41.60% | 90.03K shares | 9.58M | $97.48 | 306.49K |
| Q1 2022 | share | Increase | +12.88% | 24.70K shares | 3.96M | $93.75 | 216.45K |
| Q4 2021 | share | Increase | +53.20% | 66.58K shares | 4.32M | $84.63 | 191.75K |
| Q3 2021 | share | Decrease | -0.04% | -49 shares | -181K | $95.91 | 125.16K |
| Q2 2021 | share | Increase | +31.25% | 29.81K shares | 2.90M | $97.32 | 125.21K |
| Q1 2021 | share | Increase | +58.60% | 35.24K shares | 3.51M | $97.25 | 95.40K |
| Q4 2020 | share | Increase | +92.15% | 28.84K shares | 2.75M | $95.85 | 60.15K |
| Q3 2020 | share | Decrease | -42.72% | -23.35K shares | -3.65M | $96.16 | 31.30K |
| Q2 2020 | share | Decrease | -5.94% | -3.45K shares | 1.63M | $122 | 54.65K |
| Q1 2020 | share | Increase | +166.64% | 36.31K shares | 2.68M | $86.55 | 58.10K |
| Q4 2019 | share | Increase | +421.49% | 17.61K shares | 1.96M | $107.49 | 21.79K |
| Q3 2019 | share | Increase | +14.49% | 529 shares | 69K | $90.11 | 4.17K |
| Q2 2019 | share | Increase | +16.28% | 511 shares | 31K | $84.43 | 3.65K |
| Q1 2019 | share | Increase | +77.34% | 1.36K shares | 151K | $88.1 | 3.13K |
| Q4 2018 | share | Increase | 0.00% | 1.77K shares | 126K | $71.41 | 1.77K |